Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-033917
Filing Date
2022-02-10
Accepted
2022-02-10 11:14:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d288540dsc13g.htm SC 13G 33645
  Complete submission text file 0001193125-22-033917.txt   35128
Mailing Address 60 ROUTE DE ACACIAS GENEVA 73 V8 1211
Business Address 60 ROUTE DE ACACIAS GENEVA 73 V8 1211 011 44 207 847 5040
PICTET ASSET MANAGEMENT SA (Filed by) CIK: 0001361570 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89456 | Film No.: 22612104
SIC: 2834 Pharmaceutical Preparations